Virax Biolabs GroupVRAX 
$2.69-6.27%24h
-6.27%24h
Global rank34587
Market cap$4.87M
Change 7d-48.57%
YTD Performance94.93%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Virax Biolabs Group (VRAX)
As of December 2024, Virax Biolabs Group has a market cap of $4.87M. This makes Virax Biolabs Group the world's 34587th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Virax Biolabs Group from 2022 to 2024
-
Value:-
Market cap history of Virax Biolabs Group from 2022 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $1.48M | -44.11% |
| 2023 | $2.64M | -80.00% |
| 2022 | $13.22M | - |
VRAX Market Cap Today is $4.87M -6.27% - 6 Dec 2024
View largest stocks by market cap 
